NO306973B1 - Galenisk blanding, fremgangsmåte for fremstilling av denne, samt anvendelse derav - Google Patents
Galenisk blanding, fremgangsmåte for fremstilling av denne, samt anvendelse deravInfo
- Publication number
- NO306973B1 NO306973B1 NO944957A NO944957A NO306973B1 NO 306973 B1 NO306973 B1 NO 306973B1 NO 944957 A NO944957 A NO 944957A NO 944957 A NO944957 A NO 944957A NO 306973 B1 NO306973 B1 NO 306973B1
- Authority
- NO
- Norway
- Prior art keywords
- skin
- administration
- effected
- preparation
- active compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
- A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4221256A DE4221256C2 (de) | 1992-06-26 | 1992-06-26 | Galenische Zusammensetzung für die topische Anwendung |
PCT/DE1993/000574 WO1994000110A1 (de) | 1992-06-26 | 1993-06-24 | Galenische zusammensetzung für die topische anwendung |
Publications (3)
Publication Number | Publication Date |
---|---|
NO944957L NO944957L (no) | 1994-12-21 |
NO944957D0 NO944957D0 (no) | 1994-12-21 |
NO306973B1 true NO306973B1 (no) | 2000-01-24 |
Family
ID=6462047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO944957A NO306973B1 (no) | 1992-06-26 | 1994-12-21 | Galenisk blanding, fremgangsmåte for fremstilling av denne, samt anvendelse derav |
Country Status (21)
Country | Link |
---|---|
US (1) | US5686102A (no) |
EP (1) | EP0647132B1 (no) |
JP (1) | JPH08501077A (no) |
AT (1) | ATE131041T1 (no) |
AU (1) | AU671646B2 (no) |
CA (1) | CA2138976A1 (no) |
CZ (1) | CZ283703B6 (no) |
DE (2) | DE4221256C2 (no) |
DK (1) | DK0647132T3 (no) |
ES (1) | ES2083287T3 (no) |
FI (1) | FI946058A (no) |
GR (1) | GR3018336T3 (no) |
HK (1) | HK1002700A1 (no) |
HU (2) | HUT68984A (no) |
IL (1) | IL105946A (no) |
NO (1) | NO306973B1 (no) |
NZ (1) | NZ253001A (no) |
PL (1) | PL172328B1 (no) |
SK (1) | SK279820B6 (no) |
WO (1) | WO1994000110A1 (no) |
ZA (1) | ZA934572B (no) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733572A (en) * | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
US6088613A (en) | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
US6551576B1 (en) | 1989-12-22 | 2003-04-22 | Bristol-Myers Squibb Medical Imaging, Inc. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US5922304A (en) | 1989-12-22 | 1999-07-13 | Imarx Pharmaceutical Corp. | Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents |
US5469854A (en) | 1989-12-22 | 1995-11-28 | Imarx Pharmaceutical Corp. | Methods of preparing gas-filled liposomes |
US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US6146657A (en) | 1989-12-22 | 2000-11-14 | Imarx Pharmaceutical Corp. | Gas-filled lipid spheres for use in diagnostic and therapeutic applications |
US6001335A (en) | 1989-12-22 | 1999-12-14 | Imarx Pharmaceutical Corp. | Contrasting agents for ultrasonic imaging and methods for preparing the same |
US5585112A (en) | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US5776429A (en) | 1989-12-22 | 1998-07-07 | Imarx Pharmaceutical Corp. | Method of preparing gas-filled microspheres using a lyophilized lipids |
US5205290A (en) | 1991-04-05 | 1993-04-27 | Unger Evan C | Low density microspheres and their use as contrast agents for computed tomography |
US5874062A (en) | 1991-04-05 | 1999-02-23 | Imarx Pharmaceutical Corp. | Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents |
US20030181355A1 (en) * | 1992-05-29 | 2003-09-25 | Glenn Jeffrey S. | Method for inhibition of viral infection |
US5503973A (en) * | 1992-05-29 | 1996-04-02 | The Regents Of The University Of California | Method for inhibition of viral morphogenesis |
US5646181A (en) * | 1992-07-02 | 1997-07-08 | Research Foundation Of State University Of New York | Method and compositions for treating impotence |
US5497910A (en) * | 1994-05-05 | 1996-03-12 | Allergan, Inc. | Dropwise liquid dispensing system particularly suitable for liquids having low surface tension |
US5564596A (en) * | 1994-05-05 | 1996-10-15 | Allergan, Inc. | Multiple fluid dispensing device for low surface tension formulations |
US6743779B1 (en) | 1994-11-29 | 2004-06-01 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US5830430A (en) | 1995-02-21 | 1998-11-03 | Imarx Pharmaceutical Corp. | Cationic lipids and the use thereof |
US5997898A (en) | 1995-06-06 | 1999-12-07 | Imarx Pharmaceutical Corp. | Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery |
US6139819A (en) | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
US6231834B1 (en) | 1995-06-07 | 2001-05-15 | Imarx Pharmaceutical Corp. | Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same |
US6033645A (en) | 1996-06-19 | 2000-03-07 | Unger; Evan C. | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
WO1996040061A1 (en) * | 1995-06-07 | 1996-12-19 | Nexstar Pharmaceuticals, Inc. | Method for encapsulating pharmaceutical materials |
US6017963A (en) * | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
WO1997040679A1 (en) | 1996-05-01 | 1997-11-06 | Imarx Pharmaceutical Corp. | Methods for delivering compounds into a cell |
US5976573A (en) | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
US6414139B1 (en) | 1996-09-03 | 2002-07-02 | Imarx Therapeutics, Inc. | Silicon amphiphilic compounds and the use thereof |
CA2263568C (en) | 1996-09-11 | 2008-12-02 | Imarx Pharmaceutical Corp. | Methods for diagnostic imaging using a contrast agent and a renal vasodilator |
US6537246B1 (en) | 1997-06-18 | 2003-03-25 | Imarx Therapeutics, Inc. | Oxygen delivery agents and uses for the same |
US6143276A (en) | 1997-03-21 | 2000-11-07 | Imarx Pharmaceutical Corp. | Methods for delivering bioactive agents to regions of elevated temperatures |
US6090800A (en) | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
US6548047B1 (en) | 1997-09-15 | 2003-04-15 | Bristol-Myers Squibb Medical Imaging, Inc. | Thermal preactivation of gaseous precursor filled compositions |
US6123923A (en) | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
US20010003580A1 (en) | 1998-01-14 | 2001-06-14 | Poh K. Hui | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
CH693625A5 (it) * | 1999-02-18 | 2003-11-28 | Inpharma Sa | Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi. |
US20080108086A1 (en) * | 1999-06-02 | 2008-05-08 | Cantor Thomas L | Parathyroid hormone antagonists and uses thereof |
WO2004028444A2 (en) * | 1999-06-02 | 2004-04-08 | Scantibodies Laboratory, Inc. | Parathyroid hormone antagonists and uses thereof |
AUPQ105799A0 (en) | 1999-06-18 | 1999-07-08 | Victor Chang Cardiac Research Institute, The | Cell growth inhibition |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US7223406B2 (en) | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
AU2001278981A1 (en) * | 2000-07-21 | 2002-02-05 | Tom F Lue | Prevention and treatment of sexual arousal disorders |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
DE10106288A1 (de) * | 2001-02-02 | 2002-09-05 | Coty Bv | Revitalisierender Wirkkomplex für die Haut |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
CN1203055C (zh) | 2001-09-26 | 2005-05-25 | 朱德煦 | 治疗或预防细菌感染的方法和组合物 |
ES2431040T3 (es) * | 2002-03-08 | 2013-11-22 | Shanghai Institutes For Biological Sciences, Cas | Detección y modulación de la angiogénesis mediada por Slit y Roundabout (Robo), y sus usos |
CA2480099C (en) | 2002-03-26 | 2019-01-08 | Zensun (Shanghai) Sci-Tech. Ltd. | Erbb3 based methods and compositions for treating neoplasms |
US20030219696A1 (en) * | 2002-05-23 | 2003-11-27 | Moreland Gerald W. | Method and apparatus for preventing backflow in dental saliva evacuators |
AU2002304965A1 (en) | 2002-05-24 | 2003-12-12 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
US7517887B2 (en) * | 2003-04-09 | 2009-04-14 | General Atomics | Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
US7196093B2 (en) * | 2003-04-09 | 2007-03-27 | General Atomics | Reversible inhibitors of SAH hydrolase and uses thereof |
US7868011B2 (en) * | 2003-04-09 | 2011-01-11 | General Atomics | Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus |
DE10336841A1 (de) * | 2003-08-11 | 2005-03-17 | Rovi Gmbh & Co. Kosmetische Rohstoffe Kg | Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut |
DE10352602A1 (de) * | 2003-11-11 | 2005-06-02 | Rovi Gmbh & Co. Kosmetische Rohstoffe Kg | Kosmetisches oder therapeutisches Kombinationspräparat |
US20050118124A1 (en) * | 2003-12-01 | 2005-06-02 | Reinhart Gale M. | Compositions for treating keratinous surfaces |
CN1869002A (zh) * | 2005-05-27 | 2006-11-29 | 中国科学院上海药物研究所 | 一类非甾体雄激素受体调节剂、其制备方法和用途 |
US20100254965A1 (en) * | 2006-10-24 | 2010-10-07 | Board Of Regents ,The University Of Texas System | Adenosine Signaling in Diagnosis, Treatment, and Prevention of Priapism and Erectile Dysfunction |
CA3135595A1 (en) | 2010-06-13 | 2011-12-22 | Institute Of Biophysics, Chinese Academy Of Sciences | Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof |
WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun (Shanghai)Science & Technology Limited | Compositions and methods for treating heart failure |
EP2891712A4 (en) | 2012-07-23 | 2016-04-06 | Inst Biophysics Cn Acad Sci | METHOD OF INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN VITRICULAR MYOCYTES IN VITRO |
CA2884051A1 (en) | 2012-10-08 | 2014-04-17 | Zensun (Shanghai) Science & Technology, Ltd. | Compositions and methods for treating heart failure in diabetic patients |
EP2999499B1 (en) | 2013-05-22 | 2019-07-17 | Zensun (Shanghai) Science & Technology, Co., Ltd. | Extended release of neuregulin for treating heart failure |
EP3421044A1 (en) * | 2017-06-26 | 2019-01-02 | SastoMed GmbH | Oxygen carriers for the treatment of skin indispositions |
CN113289002A (zh) | 2020-02-24 | 2021-08-24 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0069307B1 (de) * | 1981-07-02 | 1986-03-05 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Verfahren zur Herstellung von Liposomenlösungen |
GR78151B (no) * | 1982-04-05 | 1984-09-26 | Alcon Lab Inc | |
GB2134787A (en) * | 1982-08-17 | 1984-08-22 | Sun Tech Inc | Perfluorocarbon emulsions and their preparation and use in therapy |
DE3542773A1 (de) * | 1985-12-04 | 1987-06-11 | Roehm Pharma Gmbh | Hautwirksame pharmaka mit liposomen als wirkstofftraeger |
US5204112A (en) * | 1986-06-16 | 1993-04-20 | The Liposome Company, Inc. | Induction of asymmetry in vesicles |
WO1989000848A1 (en) * | 1986-09-19 | 1989-02-09 | Chemex Pharmaceuticals, Inc. | Method for the treatment of body tissues and the administration of drugs thereto |
US5219538A (en) * | 1987-03-13 | 1993-06-15 | Micro-Pak, Inc. | Gas and oxygen carrying lipid vesicles |
US5061484A (en) * | 1988-03-11 | 1991-10-29 | Alpha Therapeutic Corporation | Perfluorochemical emulsion with stabilized vesicles |
EP0417104A4 (en) * | 1988-03-11 | 1991-10-30 | Alpha Therapeutic Corporation | Perfluorochemical emulsion with stabilized vesicles |
AU647372B2 (en) * | 1989-07-05 | 1994-03-24 | Alliance Pharmaceutical Corporation | Fluorocarbon emulsions having saturated phospholipid emulsifiers |
DE4127442C2 (de) * | 1991-08-17 | 1996-08-22 | Udo Dr Gros | Wäßrige Dispersion Fluorcarbon enthaltender Phospholipid-Vesikel und ein Verfahren zu ihrer Herstellung |
-
1992
- 1992-06-26 DE DE4221256A patent/DE4221256C2/de not_active Expired - Fee Related
-
1993
- 1993-06-08 IL IL10594693A patent/IL105946A/xx not_active IP Right Cessation
- 1993-06-24 DK DK93912638.9T patent/DK0647132T3/da active
- 1993-06-24 WO PCT/DE1993/000574 patent/WO1994000110A1/de active IP Right Grant
- 1993-06-24 AU AU43080/93A patent/AU671646B2/en not_active Ceased
- 1993-06-24 AT AT93912638T patent/ATE131041T1/de active
- 1993-06-24 CA CA002138976A patent/CA2138976A1/en not_active Abandoned
- 1993-06-24 NZ NZ253001A patent/NZ253001A/en unknown
- 1993-06-24 ES ES93912638T patent/ES2083287T3/es not_active Expired - Lifetime
- 1993-06-24 HU HU9403738A patent/HUT68984A/hu unknown
- 1993-06-24 PL PL93306535A patent/PL172328B1/pl unknown
- 1993-06-24 EP EP93912638A patent/EP0647132B1/de not_active Expired - Lifetime
- 1993-06-24 DE DE59301123T patent/DE59301123D1/de not_active Expired - Lifetime
- 1993-06-24 SK SK1565-94A patent/SK279820B6/sk unknown
- 1993-06-24 JP JP6501956A patent/JPH08501077A/ja active Pending
- 1993-06-24 CZ CZ943265A patent/CZ283703B6/cs not_active IP Right Cessation
- 1993-06-25 ZA ZA934572A patent/ZA934572B/xx unknown
-
1994
- 1994-12-21 NO NO944957A patent/NO306973B1/no not_active IP Right Cessation
- 1994-12-23 FI FI946058A patent/FI946058A/fi unknown
-
1995
- 1995-06-21 HU HU95P/P00293P patent/HU211644A9/hu unknown
- 1995-12-08 GR GR950403447T patent/GR3018336T3/el unknown
-
1996
- 1996-07-03 US US08/674,851 patent/US5686102A/en not_active Expired - Lifetime
-
1998
- 1998-03-09 HK HK98101892A patent/HK1002700A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1002700A1 (en) | 1998-09-11 |
EP0647132A1 (de) | 1995-04-12 |
ES2083287T3 (es) | 1996-04-01 |
NO944957L (no) | 1994-12-21 |
FI946058A0 (fi) | 1994-12-23 |
NZ253001A (en) | 1996-08-27 |
GR3018336T3 (en) | 1996-03-31 |
DK0647132T3 (da) | 1996-01-08 |
DE4221256A1 (de) | 1994-01-05 |
DE4221256C2 (de) | 1997-07-10 |
CZ283703B6 (cs) | 1998-06-17 |
SK156594A3 (en) | 1995-07-11 |
AU671646B2 (en) | 1996-09-05 |
IL105946A (en) | 1997-02-18 |
HU211644A9 (en) | 1995-12-28 |
AU4308093A (en) | 1994-01-24 |
NO944957D0 (no) | 1994-12-21 |
ZA934572B (en) | 1994-01-31 |
EP0647132B1 (de) | 1995-12-06 |
CZ326594A3 (en) | 1995-07-12 |
ATE131041T1 (de) | 1995-12-15 |
IL105946A0 (en) | 1993-10-20 |
DE59301123D1 (de) | 1996-01-18 |
WO1994000110A1 (de) | 1994-01-06 |
JPH08501077A (ja) | 1996-02-06 |
FI946058A (fi) | 1994-12-23 |
US5686102A (en) | 1997-11-11 |
HUT68984A (en) | 1995-08-28 |
CA2138976A1 (en) | 1993-12-27 |
SK279820B6 (sk) | 1999-04-13 |
HU9403738D0 (en) | 1995-02-28 |
PL172328B1 (pl) | 1997-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO306973B1 (no) | Galenisk blanding, fremgangsmåte for fremstilling av denne, samt anvendelse derav | |
DE69331335D1 (de) | Topisches und transdermales abgabesystem unter verwendung von submikron-ölkügelchen | |
HU892559D0 (en) | Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient | |
CA2138974A1 (en) | Dermatological agent for aiding oxygen transport in the skin | |
AU686123B2 (en) | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity | |
GB2326093A (en) | Avermectin formulation | |
WO1998013024A3 (en) | Hyaluronic drug delivery system | |
ZA934570B (en) | Phospholipid-containing cosmetic | |
ES8700049A1 (es) | Un procedimiento para la preparacion de una composicion topica para reducir la secrecion de sebo | |
CA2078869A1 (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use | |
IL87778A0 (en) | Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation | |
IE810891L (en) | Topical formulation | |
PT80961A (en) | Process for the preparation of new pharmaceutical compounds containing mixtures of 4,9-dihydro-4-(1-methyl-4-piperydilene)-10h-benzoý4,5¨-cycloheptaý1,2-b¨thyophene-10-one and antiasthmati c xantines as active ingredient | |
IT8521528A0 (it) | Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo. | |
ITMI922216A1 (it) | Nitrobenzoilalanine, procedimento per la loro preparazione, loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN DECEMBER 2000 |